Testing effectiveness (Phase 2)Study completedNCT01403636What this trial is testingInvestigational SAR245409 in Patients With Certain Lymphoma or LeukemiaWho this might be right forLymphoma Sanofi 167
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Testing effectiveness (Phase 2)Ended earlyNCT05720052What this trial is testingMS-553 in Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forRelapsed or Refractory B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+4 more MingSight Pharmaceuticals, Inc 8
Testing effectiveness (Phase 2)Study completedNCT00002521What this trial is testingCombination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Temple University
Very early researchStudy completedNCT01239875What this trial is testingVaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+13 more Mayo Clinic 16
Early research (Phase 1)Ended earlyNCT00176475What this trial is testingIrradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm University of Medicine and Dentistry of New Jersey 2
Testing effectiveness (Phase 2)Study completedNCT01165112What this trial is testingBendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin Lymphoma University of Washington 48
Early research (Phase 1)Active Not RecruitingNCT05512390What this trial is testingAssess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Who this might be right forDiffuse Large B-Cell LymphomaChronic Lymphocytic LeukemiaFollicular Lymphoma AbbVie 39
Testing effectiveness (Phase 2)Ended earlyNCT05328102What this trial is testingPhase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)Who this might be right forDiffuse Large-cell B-cell Lymphoma Xencor, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT01812005What this trial is testingAlisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+8 more Ohio State University Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05202782What this trial is testingZanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Associated With Chronic InflammationEBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma, Not Otherwise Specified+16 more Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105What this trial is testingAssess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer TherapiesWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Regeneron Pharmaceuticals 515
Early research (Phase 1)Ended earlyNCT01116154What this trial is testingVorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more City of Hope Medical Center 30
Not applicableStudy completedNCT00534118What this trial is testingDonor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)UnknownNCT02892695What this trial is testingPCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and LymphomaWho this might be right forAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06062641What this trial is testingSelinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCLWho this might be right forRelapsed or Refractory B-cell Lymphoma Ruijin Hospital 50
Early research (Phase 1)Looking for participantsNCT06544265What this trial is testingSynKIR-310 for Relapsed/Refractory B-NHLWho this might be right forB Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more Verismo Therapeutics 36
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT02825836What this trial is testingPhase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL SubjectsWho this might be right forRelapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia+2 more Telios Pharma, Inc. 130
Early research (Phase 1)Study completedNCT00293488What this trial is testingSL-11047 in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forLymphoma Progen Pharmaceuticals 20